Patrizia Lorenzini

Clinical Epidemiology and Survival of Progressive Multifocal Leukoencephalopathy in the Era of Highly Active Antiretroviral Therapy: Data from the Italian Registry Investigative Neuro AIDS (IRINA)

Andrea Antinori, Antonella Cingolani, Patrizia Lorenzini et al. · Journal of NeuroVirology · 2003 · 160 citations · Full text

Public Health, Neurology, Neuroscience +7

Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count

Andrea Antinori, Stefania Cicalini, Silvia Meschi et al. · Clinical Infectious Diseases · 2022 · 137 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients

Mauro Zaccarelli, Valerio Tozzi, Patrizia Lorenzini et al. · AIDS · 2005 · 136 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Prevalence and risk factors for human immunodeficiency virus–associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort

Valerio Tozzi, Pietro Balestra, Patrizia Lorenzini et al. · Journal of NeuroVirology · 2005 · 130 citations

Medicine, Neurology, Neuroscience +17

Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome

Alessandra Sacchi, Germana Grassi, Veronica Bordoni et al. · Cell Death and Disease · 2020 · 117 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16